Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103361 · ClinicalTrials.gov registry record
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
A clinical trial of Pregnancy and Psoriasis, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT02103361 is a study of Pregnancy and Psoriasis that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 200 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02103361, a study of Pregnancy and Psoriasis, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.
Conditions Studied
Interventions
- DRUG Ustekinumab
- DRUG Guselkumab
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-11 |
| Est. Completion | 2031-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02103361
The ClinicalTrials.gov registry entry for NCT02103361 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Ustekinumab is the first listed.
NCT02103361 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02103361 about?
NCT02103361 is a clinical study titled "Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project". The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it ...
What is the current status of trial NCT02103361?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2013-11. Estimated completion is 2031-02.
What conditions does trial NCT02103361 study?
This clinical trial studies the following conditions: Pregnancy, Psoriasis, Crohn Disease, Psoriatic Arthritis.
What interventions are being tested in trial NCT02103361?
The interventions under investigation include: Ustekinumab (DRUG), Guselkumab (DRUG).
Who is sponsoring clinical trial NCT02103361?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02103361 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.